{
  "id": "64403be357b1c7a31500004e",
  "type": "factoid",
  "question": "What was the duration of the follow-up period of patients in the PEACHTREE clinical trial?",
  "ideal_answer": "The patient follow-up period in the PEACHTREE trial lasted 24 weeks (6 months).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34322164"
  ],
  "snippets": [
    {
      "text": "Recent results from the PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398), a phase III trial with two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks, showed the significant improvement in visual acuity and reduction in central subfield thickness, all without increasing the risk of elevated intraocular pressure or accelerated cataract progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34322164",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "24 weeks, 6 months"
}